413 related articles for article (PubMed ID: 15120942)
21. CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia.
Kosugi N; Ebihara Y; Nakahata T; Saisho H; Asano S; Tojo A
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):505-11. PubMed ID: 15701834
[TBL] [Abstract][Full Text] [Related]
22. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
23. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia.
Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF
Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960
[TBL] [Abstract][Full Text] [Related]
25. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
26. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
27. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
Mahmud N; Patel H; Hoffman R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
[TBL] [Abstract][Full Text] [Related]
28. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
[TBL] [Abstract][Full Text] [Related]
29. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
31. Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells.
Flores-Guzmán P; Martínez-Jaramillo G; Montesinos JJ; Valencia I; Mayani H
Cytotherapy; 2006; 8(3):299-307. PubMed ID: 16793738
[TBL] [Abstract][Full Text] [Related]
32. Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors.
Koller MR; Manchel I; Brott DA; Palsson Bø
Exp Hematol; 1996 Nov; 24(13):1484-93. PubMed ID: 8950231
[TBL] [Abstract][Full Text] [Related]
33. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
34. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
35. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
[TBL] [Abstract][Full Text] [Related]
36. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
[TBL] [Abstract][Full Text] [Related]
37. Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS).
Martín-Henao GA; Inglés-Esteve J; Cancelas JA; García J
Bone Marrow Transplant; 1996 Sep; 18(3):603-9. PubMed ID: 8879625
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia modifies proliferation and differentiation of CD34(+) CML cells.
Desplat V; Faucher JL; Mahon FX; Dello Sbarba P; Praloran V; Ivanovic Z
Stem Cells; 2002; 20(4):347-54. PubMed ID: 12110704
[TBL] [Abstract][Full Text] [Related]
39. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
[TBL] [Abstract][Full Text] [Related]
40. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
Eaves C; Eaves A
Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
